As the field of artificial intelligence continues to rapidly advance, there is growing interest in its potential applications to drug development. With the ability to process vast amounts of data and make complex predictions, AI has the potential to greatly accelerate the drug discovery process, leading to more efficient and effective treatments for a range of diseases. However, there are also important ethical and regulatory considerations that must be taken into account when using AI in drug development.